Literature DB >> 25926108

Toll-like receptor 3 (TLR3) and the development of type 1 diabetes mellitus.

Taís Silveira Assmann1, Letícia de Almeida Brondani1, Ana Paula Bouças1, Luís Henrique Canani2, Daisy Crispim1.   

Abstract

Type 1 diabetes mellitus (T1DM) is a chronic, progressive autoimmune disease characterized by metabolic decompensation often leading to dehydration and ketoacidosis. Viral agents seem to play an important role in triggering the autoimmune destruction that leads to the development of T1DM. Among several viral strains investigated so far, the enterovirus family has been consistently associated with the onset of T1DM in humans. One of the mediators of viral damage is the double-stranded RNA (dsRNA) generated during replication and transcription of viral RNA and DNA. The Toll-like receptor 3 (TLR3) gene codes for an endoplasmic receptor of the pattern-recognition receptors (PRRs) family that recognizes dsRNA, plays an important role in the innate immune response triggered by viral infection. Binding of dsRNA to the TLR3 triggers the release of proinflammatory cytokines, such as interferons, which exhibit potent antiviral action; thus, protecting uninfected cells and inducing apoptosis of infected ones. Therefore, the TLR3 gene is a good candidate for the development of T1DM. Within this context, the objective of the present review was to address the role of the TLR3 gene in the development of T1DM.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25926108     DOI: 10.1590/2359-3997000000003

Source DB:  PubMed          Journal:  Arch Endocrinol Metab        ISSN: 2359-3997            Impact factor:   2.309


  9 in total

Review 1.  Lipid deposition and metaflammation in diabetic kidney disease.

Authors:  Alla Mitrofanova; Antonio M Fontanella; Sandra Merscher; Alessia Fornoni
Journal:  Curr Opin Pharmacol       Date:  2020-11-01       Impact factor: 5.547

Review 2.  NLRP3 Inflammasome at the Interface of Inflammation, Endothelial Dysfunction, and Type 2 Diabetes.

Authors:  Ilona M Gora; Anna Ciechanowska; Piotr Ladyzynski
Journal:  Cells       Date:  2021-02-03       Impact factor: 6.600

Review 3.  Potential Mechanisms Underlying Inflammation-Enhanced Aminoglycoside-Induced Cochleotoxicity.

Authors:  Meiyan Jiang; Farshid Taghizadeh; Peter S Steyger
Journal:  Front Cell Neurosci       Date:  2017-11-21       Impact factor: 5.505

Review 4.  Innate Viral Sensor MDA5 and Coxsackievirus Interplay in Type 1 Diabetes Development.

Authors:  Samuel I Blum; Hubert M Tse
Journal:  Microorganisms       Date:  2020-07-03

5.  Attenuation of inflammation in streptozotocin-induced diabetic rabbits by Matricaria chamomilla oil: A focus on targeting NF-κB and NLRP3 signaling pathways.

Authors:  Saeid Saghahazrati; Seyed Abdulmajid Ayatollahi; Farzad Kobarfard; Bagher Minaii Zang
Journal:  Chin Herb Med       Date:  2019-12-24

Review 6.  The role of the innate immune system in destruction of pancreatic beta cells in NOD mice and humans with type I diabetes.

Authors:  Ningwen Tai; F Susan Wong; Li Wen
Journal:  J Autoimmun       Date:  2016-03-24       Impact factor: 7.094

Review 7.  Virtual Screening Approaches towards the Discovery of Toll-Like Receptor Modulators.

Authors:  Lucía Pérez-Regidor; Malik Zarioh; Laura Ortega; Sonsoles Martín-Santamaría
Journal:  Int J Mol Sci       Date:  2016-09-09       Impact factor: 5.923

Review 8.  Inflammasome NLRP3 Potentially Links Obesity-Associated Low-Grade Systemic Inflammation and Insulin Resistance with Alzheimer's Disease.

Authors:  Anna Litwiniuk; Wojciech Bik; Małgorzata Kalisz; Agnieszka Baranowska-Bik
Journal:  Int J Mol Sci       Date:  2021-05-25       Impact factor: 5.923

9.  Analysis of immune cell components and immune-related gene expression profiles in peripheral blood of patients with type 1 diabetes mellitus.

Authors:  Jian Lin; Yuanhua Lu; Bizhou Wang; Ping Jiao; Jie Ma
Journal:  J Transl Med       Date:  2021-07-26       Impact factor: 5.531

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.